PTCT
Price
$75.64
Change
+$0.20 (+0.27%)
Updated
Dec 12 closing price
Capitalization
6.07B
73 days until earnings call
Intraday BUY SELL Signals
VRDN
Price
$32.31
Change
-$0.26 (-0.80%)
Updated
Dec 12 closing price
Capitalization
3.08B
82 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PTCT vs VRDN

Header iconPTCT vs VRDN Comparison
Open Charts PTCT vs VRDNBanner chart's image
PTC Therapeutics
Price$75.64
Change+$0.20 (+0.27%)
Volume$941.3K
Capitalization6.07B
Viridian Therapeutics
Price$32.31
Change-$0.26 (-0.80%)
Volume$943.61K
Capitalization3.08B
PTCT vs VRDN Comparison Chart in %
PTCT
Daily Signal:
Gain/Loss:
VRDN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Nektar Therapeutics (NASDAQ:NKTR), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.21B. The market cap for tickers in the group ranges from 58 to 114.69B. VRTX holds the highest valuation in this group at 114.69B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 65%. NBY experienced the highest price growth at 158%, while BPTSY experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -11%. For the same stocks of the Industry, the average monthly volume growth was -7% and the average quarterly volume growth was 72%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 80
Price Growth Rating: 54
SMR Rating: 92
Profit Risk Rating: 93
Seasonality Score: 17 (-100 ... +100)

Market Cap

The average market capitalization across the group is 4.58B. The market cap for tickers in the group ranges from 3.11B to 6.06B. PTCT holds the highest valuation in this group at 6.06B. The lowest valued company is VRDN at 3.11B.

High and low price notable news

The average weekly price growth across all stocks in the group was -1%. For the same group, the average monthly price growth was 8%, and the average quarterly price growth was 76%. VRDN experienced the highest price growth at 0%, while PTCT experienced the biggest fall at -3%.

Volume

The average weekly volume growth across all stocks in the group was -44%. For the same stocks of the group, the average monthly volume growth was -62% and the average quarterly volume growth was 10%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 75
P/E Growth Rating: 56
Price Growth Rating: 38
SMR Rating: 99
Profit Risk Rating: 68
Seasonality Score: 50 (-100 ... +100)
VS
PTCT vs. VRDN commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTCT is a Hold and VRDN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (PTCT: $75.44 vs. VRDN: $32.57)
Brand notoriety: PTCT and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PTCT: 45% vs. VRDN: 52%
Market capitalization -- PTCT: $6.07B vs. VRDN: $3.08B
PTCT [@Biotechnology] is valued at $6.07B. VRDN’s [@Biotechnology] market capitalization is $3.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTCT’s FA Score shows that 1 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • PTCT’s FA Score: 1 green, 4 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, PTCT is a better buy in the long-term than VRDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTCT’s TA Score shows that 3 TA indicator(s) are bullish while VRDN’s TA Score has 3 bullish TA indicator(s).

  • PTCT’s TA Score: 3 bullish, 5 bearish.
  • VRDN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both PTCT and VRDN are a bad buy in the short-term.

Price Growth

PTCT (@Biotechnology) experienced а -3.10% price change this week, while VRDN (@Biotechnology) price change was +0.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

PTCT is expected to report earnings on Feb 24, 2026.

VRDN is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTCT($6.07B) has a higher market cap than VRDN($3.08B). VRDN (69.901) and PTCT (67.125) have similar YTD gains . PTCT has higher annual earnings (EBITDA): 912M vs. VRDN (-298.48M). PTCT has more cash in the bank: 1.69B vs. VRDN (491M). VRDN has less debt than PTCT: VRDN (21.6M) vs PTCT (410M). PTCT has higher revenues than VRDN: PTCT (1.78B) vs VRDN (70.8M).
PTCTVRDNPTCT / VRDN
Capitalization6.07B3.08B197%
EBITDA912M-298.48M-306%
Gain YTD67.12569.90196%
P/E Ratio8.80N/A-
Revenue1.78B70.8M2,513%
Total Cash1.69B491M344%
Total Debt410M21.6M1,898%
FUNDAMENTALS RATINGS
PTCT vs VRDN: Fundamental Ratings
PTCT
VRDN
OUTLOOK RATING
1..100
8482
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
52
Fair valued
PROFIT vs RISK RATING
1..100
7760
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
4136
P/E GROWTH RATING
1..100
12100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VRDN's Valuation (52) in the Biotechnology industry is somewhat better than the same rating for PTCT (99). This means that VRDN’s stock grew somewhat faster than PTCT’s over the last 12 months.

VRDN's Profit vs Risk Rating (60) in the Biotechnology industry is in the same range as PTCT (77). This means that VRDN’s stock grew similarly to PTCT’s over the last 12 months.

VRDN's SMR Rating (98) in the Biotechnology industry is in the same range as PTCT (100). This means that VRDN’s stock grew similarly to PTCT’s over the last 12 months.

VRDN's Price Growth Rating (36) in the Biotechnology industry is in the same range as PTCT (41). This means that VRDN’s stock grew similarly to PTCT’s over the last 12 months.

PTCT's P/E Growth Rating (12) in the Biotechnology industry is significantly better than the same rating for VRDN (100). This means that PTCT’s stock grew significantly faster than VRDN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PTCTVRDN
RSI
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
PTCT
Daily Signal:
Gain/Loss:
VRDN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PFPFX54.730.53
+0.98%
Poplar Forest Partners A
EITMX126.910.34
+0.27%
Eaton Vance Tx-Mgd Growth 1.1 I
SQBIX15.330.04
+0.26%
X-Square Balanced Fund, LLC Instl
FINSX48.78N/A
N/A
Fidelity Advisor New Insights I
OAIEX15.36-0.05
-0.32%
Optimum International A

PTCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTCT has been loosely correlated with CGON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PTCT jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCT
1D Price
Change %
PTCT100%
+1.81%
CGON - PTCT
46%
Loosely correlated
-0.31%
BEAM - PTCT
45%
Loosely correlated
+0.40%
VRDN - PTCT
45%
Loosely correlated
-0.09%
XNCR - PTCT
44%
Loosely correlated
-0.58%
SYRE - PTCT
44%
Loosely correlated
-0.87%
More

VRDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with NUVL. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
-0.09%
NUVL - VRDN
56%
Loosely correlated
+0.16%
XNCR - VRDN
54%
Loosely correlated
-0.58%
CLDX - VRDN
53%
Loosely correlated
-0.89%
SYRE - VRDN
52%
Loosely correlated
-0.87%
CRNX - VRDN
50%
Loosely correlated
+2.60%
More